Mayo Clinic Cardiovascular CME

Obesity, Hypertension, and Risk Factors in Terms of Prevention and Decreasing the Risk of HfpEF   Guest: Affan Irfan, M.D., Ph.D. Host: Stephen L. Kopecky, M.D.   HFpEF is a type of heart failure where the heart pumps normally but becomes stiff. This leads to fatigue, shortness of breath, and fluid retention. It is closely linked to obesity, hypertension, and metabolic disorders, with cases rising as these conditions become more common.   Topics Discussed: What is HFpEF and its risk factors? How common are obesity and hypertension, and how often do they lead to HFpEF? How do you diagnose HFpEF? How effective are weight loss, diet, and exercise in preventing HFpEF? What medical and public health strategies help reduce these risk factors and HFpEF cases?    Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Aortic Regurgitation: Beyond the Valve   Guest: Vidhu Anand, M.B.B.S. Host: Kyle Klarich, M.D.   In this episode of Mayo Clinic’s “Interviews With the Experts,” Dr. Klarich and Dr. Anand discuss evolving approaches to assessing left ventricular remodeling in chronic aortic regurgitation. Dr. Vidhu Anand discusses research showing that LV volumes, global longitudinal strain, and myocardial fibrosis can detect dysfunction earlier than traditional guideline thresholds. Listeners can expect to better understand the role of multimodality imaging, extra valvular involvement, and practical steps echocardiographers can take to optimize AR assessment.    Topics Discussed: What imaging markers help detect early myocardial dysfunction in AR, and how do they assist in risk stratification? Guidelines traditionally focus on LV dimensions and ejection fraction for surgical decision-making in AR. Is there any data that guidelines may not be capturing patients at the optimal time? Is there a role of multimodality imaging in AR? What practical steps can a sonographer or echocardiographer today to bring their AR assessment closer to what your research suggests is optimal?     Please reference Dr. Anand's research article(s) here: https://pubmed.ncbi.nlm.nih.gov/39545891/ https://pubmed.ncbi.nlm.nih.gov/33253815/ https://pubmed.ncbi.nlm.nih.gov/39218370/   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Presentation, Evaluation, and Management of Premature Ventricular Contractions   Guest: Alan M. Sugrue, M.B., B.Ch., B.A.O. Host: Anthony H. Kashou, M.D.   In this episode, Dr. Anthony Kashou and Dr. Alan Sugrue cover a practical, evidence-based approach to premature ventricular contractions (PVCs), from incidental findings to high-burden, high-risk presentations. Listeners will gain tools to differentiate benign from pathologic PVCs, understand when to monitor versus refer, and recognize the role of catheter ablation in improving outcomes.   Topics Discussed: PVCs show up on Holters and ECGs all the time — how do you decide when they matter? How often do PVCs cause cardiomyopathy, and when should we act? When should we consider ablation even if the patient is asymptomatic? What’s the biggest misconception about PVC ablation today? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

Tricuspid Regurgitation: New Insights and Implications for Clinical Practice   Guest: Vidhu Anand, M.B.B.S. Host: Kyle Klarich, M.D.   This episode of Mayo Clinic’s “Interviews With the Experts,” explores new insights into tricuspid regurgitation and its implications for clinical practice. Dr. Vidhu Anand discusses the dynamic nature of TR, its impact on prognosis, and the importance of close monitoring even when the condition appears to improve. The conversation highlights evolving guideline considerations, patient risk stratification, and how AI and machine learning may soon support earlier, more personalized interventions. Listeners will gain practical takeaways on when to escalate care and how to optimize long-term outcomes for TR patients.   Topics Discussed: How has our understanding of the natural history of tricuspid regurgitation changed, and what does this mean for the way we monitor and counsel patients? What are the current indications for intervention in isolated TR? How is TR currently classified? Are there any novel classifications based on patient’s risk profile, since comorbidities play an important role in TR? Review of Mayo Clinic study using AI/machine learning and outcomes in TR.   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Cardiovascular Diet Myths   Guest: Stephen Kopecky, M.D. Host: Sharonne Hayes, M.D.   Since 2018, Trans-Fats are prohibited from being a food additive in the US. In this episode of “Interviews With the Experts,” Dr. Stephen Kopecky discussed how trans fats are still in our food, just not as much as pre-2018, and the main sources of trans fat are ultra-processed foods. Listeners will learn what foods scan raise your blood cholesterol (LDL-C) levels, increase heart attack risk, accelerate the aging process, and slow the aging process.   Topics Discussed: Are some trans-fats still sneaking into our food? If a person eats food high in cholesterol, can blood levels of cholesterol (LDL-C) go up? Which artificial sweeteners increase CV risk? Can diet actually speed up or slow down the aging process?    Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.